As India grapples with a rising diabetes burden, Unicharm India is quietly reshaping an often-overlooked aspect of patient care—urinary incontinence. Through its Lifree portfolio, the company is positioning itself at the intersection of healthcare, hygiene, and dignity-led innovation, addressing a silent crisis that affects millions across the subcontinent.
Recognizing that a significant portion of diabetes patients experience symptoms like frequent urination and incontinence—yet rarely seek professional solutions due to deep-seated social stigma—Unicharm India has strategically expanded its product line. This specialized adult diaper range is specifically tailored for the unique physiological and lifestyle needs associated with diabetes care, bridging the gap between medical necessity and daily comfort.
Innovation Rooted in Research
At the core of this expansion is the newly launched Lifree Durable Absorb range, engineered to deliver a consistent 8–12 hours of protection. This long-wear capability is crucial for patients managing chronic conditions, as it minimizes the psychological stress of frequent changes.
The portfolio currently includes four distinct variants, each developed through rigorous research and comparative testing across India and Japan. This collaborative development process reflects the company’s focus on combining global technical expertise with local cultural insights, ensuring that the products are suited for the Indian climate and consumer preferences.
Leadership with a Purpose
Driving this transformation is Keisuke Takatsuto, Assistant General Manager of Lifree. Takatsuto is steadily building the brand’s footprint in India with a strong focus on category creation rather than mere product penetration. Under his leadership, Lifree is evolving from a functional hygiene offering into a purpose-driven brand centered on dignity, independence, and an enhanced quality of life.
His strategic approach blends three critical pillars:
Consumer Education: Simplifying the science of hygiene.
Medical Partnerships: Aligning with healthcare providers to validate the category.
Culturally Sensitive Communication: Softening the narrative to break long-standing taboos.
For Takatsuto, the initiative goes beyond simple product innovation; it is about restoring the fundamental confidence of patients who often suffer in silence.
“With diabetes cases continuing to rise in India, urinary incontinence is impacting not just physical comfort but also emotional well-being. Our aim is to provide a solution that enables freedom of movement, comfort, and peace of mind—making Lifree a trusted partner in daily care,” he notes.
Breaking the Stigma
The company is also tackling the larger societal challenge: normalizing the conversation around adult diaper usage. Despite being a common clinical symptom of advanced diabetes, incontinence remains heavily stigmatized, often leading patients to isolate themselves or delay seeking help.
To address this, Lifree is actively collaborating with doctors, caregivers, and nursing communities to reposition diaper usage as a proactive wellness choice rather than a "last resort" for the bedridden. Takatsuto has been instrumental in steering these partnerships, ensuring that awareness-building goes hand-in-hand with product accessibility.
This awareness-led approach was recently highlighted at the Diabetes India 2026 – World Congress of Diabetes in Hyderabad. There, Unicharm India hosted a high-level panel discussion to drive dialogue around patient-centric management, shifting the focus from just "controlling blood sugar" to "improving the quality of life."
By combining high-tech product innovation with sustained awareness efforts and leadership-driven brand building, Unicharm India is not just expanding a market category—it is attempting to redefine how chronic care is perceived, managed, and lived in modern India.
Disclaimer: This is a sponsored article. All possible measures have been taken to ensure accuracy, reliability, timeliness and authenticity of the information; however Outlookindia.com does not take any liability for the same. Using of any information provided in the article is solely at the viewers’ discretion.
